Neurocrine Biosciences
NBIX
#1492
Rank
$15.50 B
Marketcap
$152.57
Share price
-0.24%
Change (1 day)
12.66%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company